Pemphigus Completed Phase 2 Trials for Filgrastim (DB00099)

IndicationStatusPhase
DBCOND0001806 (Pemphigus)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00010413Phase II Study of High-Dose Cyclophosphamide in Patients With Refractory PemphigusTreatment